Comparative Effectiveness Study Examines Safety, Efficacy of Biosimilar in Clinical Trial, Real-World Practice

Comparative Effectiveness Study Examines Safety, Efficacy of Biosimilar in Clinical Trial, Real-World Practice

The results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat chemotherapy-induced neutropenia in patients with breast cancer. The biosimilar to filgrastim was granted United States Food and Drug Administration (FDA) approval in 2015 for several indications, including the prevention of chemotherapy-induced neutropenia. […]

Assessing The Value Of Wearables In Interventional Clinical Trials

Assessing The Value Of Wearables In Interventional Clinical Trials

By Prem Meyyan and Stephen Ames, Fuld + Company Advancements in biosensor technology are becoming increasingly common in the consumer space, with wrists adorned with Fitbits or similar devices, clothing embedded with “intelligent” fibers, and personal safety devices seen in healthcare facilities across the nation. Our culture is increasingly accustomed to tracking health metrics through […]

PRA Named International Clinical Research Company of the Year

PRA Named International Clinical Research Company of the Year

PRA Named International Clinical Research Company of the Year PRA Health Sciences International Team PRA Health Sciences, Inc. RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in […]

Splash Pharmaceuticals Announces Dose Escalation in Phase I Clinical Trial in Platinum-resistant Ovarian Cancer …

Splash Pharmaceuticals Announces Dose Escalation in Phase I Clinical Trial in Platinum-resistant Ovarian Cancer …

SAN DIEGO–(BUSINESS WIRE)–May 24, 2018–Splash Pharmaceuticals, Inc. (“Splash”), a closely held private biopharmaceutical company that develops novel cancer therapies, announced the successful completion of the first safety cohort of patients and initiation of dose escalation in its ongoing clinical trial in platinum-resistant ovarian cancer patients. The Phase I trial is being conducted at Rutgers Cancer […]

Experimental Ebola treatment in Phase 1 clinical trial

Experimental Ebola treatment in Phase 1 clinical trial

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is examining the safety and tolerability of a single monoclonal antibody called mAb114, which was developed by scientists at the National Institute of Allergy […]

NIH begins testing Ebola treatment in early-stage trial

NIH begins testing Ebola treatment in early-stage trial

News Release Wednesday, May 23, 2018 Scientists developed monoclonal antibody from Ebola survivor. A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is examining the safety and tolerability of a single monoclonal antibody called […]

1 2 3 40